Paul Jellinger is an Endocrinology/Metabolic physician. OpenAlex indexes 66 publications with 13,825 citations (h-index 36).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1150 N 35th Ave
#590
Hollywood, FL 33021
Telephone
954-963-7191Registry record last updated 27 Sept 2012.
Industry payments
47 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Siemens Medical Solutions USA, Inc.Program year20251 payment
- Novo Nordisk IncProgram year202516 payments
- Corcept TherapeuticsProgram year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
44%GLP-1 receptor agonist15.4%Ozempic67%Mounjaro14%Trulicity11%Rybelsus6%Victoza 3-Pak3%Part D<11 patientsBiguanide (metformin)11.1%Metformin Hcl75%Metformin Hcl Er25%Part D≥70 patients+ 5 more classes in this area
Cardiovascular
39.1%Statin19%Atorvastatin Calcium62%Rosuvastatin Calcium36%Livalo2%Part D<11 patientsCholesterol absorption inhibitor8.7%Ezetimibe100%Part D≥72 patients+ 6 more classes in this area
Hormonal (systemic)
16%l-Thyroxine14.8%Levothyroxine Sodium51%Synthroid49%Part D≥58 patientsl-Triiodothyronine0.7%Liothyronine Sodium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases
Journal of Diabetes and its Complications
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”